facebook_pixel

Equity Strategies

Equity Strategy 25 July 2013
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Frasers Commercial Trust: Time To Buy. 3Q Payout Up 31.2%

Frasers Commercial Trust: Time To Buy. 3Q Payout Up 31.2%

* FRASERS Commercial Trust (FCOT) said its distribution to unitholders for the third quarter rose by 31.2 per cent to $14.4 million, boosted by higher revenue contribution from its Australian properties and lower interest costs. * The redemption of 319.7 million convertible perpetual preferred units in January and April also led to an increase in […]

FIND OUT MORE

Equity Strategy 18 July 2013
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Genting Berhad: Uptrend Starting. Profit Potential: 20.00%

Genting Berhad: Uptrend Starting. Profit Potential: 20.00%

* Genting Berhad, an investment holding company, engages in leisure and hospitality, gaming and entertainment, resort, oil palm plantation, power generation, property development and management, tours and travel related services, genomics research and development, and oil and gas exploration and development activities worldwide. The company operates in five segments: Leisure and Hospitality, Power, Plantation, Oil […]

FIND OUT MORE

Equity Strategy 15 July 2013
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Regeneron Pharmaceuticals: Uptrend Has Started. Profit Potential: 12.39%

Regeneron Pharmaceuticals: Uptrend Has Started. Profit Potential: 12.39%

* Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and  commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders * The company offers EYLEA […]

FIND OUT MORE